NorthWest Biotherapeutics Inc (NWBO)

[extrooper]

An 85 million long position in NWBO would garner them at least est $500 million on a MHRA approval, which would result in other countries approving based on MHRA cooperative agreements. Whereas, a short position, if by some miracle paid off , would net them about $50 million.

Just looking at very simple math and concluding based on most likely turn of events being an approval, makes the long position a huge ROI . The long hypothesis could be over $10 per share on a partnership , whereas a buyout could easily garner $20 + per share by conservative estimates making that payday huge for the owner of 85 million shares at $1.7B .